The Value of Troponin as a Biomarker of Chemotherapy-Induced Cardiotoxicity

The Value of Troponin as a Biomarker of Chemotherapy-Induced Cardiotoxicity

In cancer survivors, cardiac dysfunction is the main cause of mortality. Cardiotoxicity represents a decline in cardiac function associated with cancer therapy, and the risk factors include smoking, dyslipidemia, an age of over 60 years, obesity, and a history of coronary artery disease, diabetes, a...

Full description

Bibliographic Details
Main Authors: Victorita Sorodoc, Oana Sirbu, Catalina Lionte, Raluca Ecaterina Haliga, Alexandra Stoica, Alexandr Ceasovschih, Ovidiu Rusalim Petris, Mihai Constantin, Irina Iuliana Costache, Antoniu Octavian Petris, Paula Cristina Morariu, Laurentiu Sorodoc
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Life
Subjects:
cardiotoxicity
troponin
biomarkers
cancer
chemotherapy
cardiac dysfunction
Online Access:https://www.mdpi.com/2075-1729/12/8/1183

Internet

https://www.mdpi.com/2075-1729/12/8/1183

Similar Items